A study showed that CCND1 in MCF-7 breast cancer cells using CKI was significantly down-regulated compared with untreated cells [43].Therefore, CCND1 is predicted to be a significant target of CKI for the treatment of GC. The gene discussed is CCND1; the disease is breast carcinoma.